FDA Inspection 1054739 — Hikma Pharmaceuticals USA, Inc.
The FDA completed an inspection of Hikma Pharmaceuticals USA, Inc. on Apr 13, 2018 in Eatontown, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 13, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Eatontown, NJ (United States)